0001055726-21-000007.txt : 20210203 0001055726-21-000007.hdr.sgml : 20210203 20210203191242 ACCESSION NUMBER: 0001055726-21-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210201 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shea Jacqueline Elizabeth CENTRAL INDEX KEY: 0001771498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 21588060 MAIL ADDRESS: STREET 1: C/O INOVIO PHARMACEUTICALS, INC. STREET 2: 660 W. GERMANTOWN PIKE, SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wf-form4_161239754472771.xml FORM 4 X0306 4 2021-02-01 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001771498 Shea Jacqueline Elizabeth 660 W. GERMANTOWN PIKE PLYMOUTH MEETING PA 19462 0 1 0 0 Chief Operating Officer Common Stock 2021-02-01 4 M 0 22376 3.62 A 66871 D Common Stock 2021-02-01 4 S 0 22376 15.06 D 44495 D Common Stock 2021-02-01 4 S 0 5960 15 D 38535 D Common Stock Option 3.62 2021-02-01 4 M 0 22376 0 D 2019-03-25 2029-03-25 Common Stock 22376.0 100000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. These transactions were executed in multiple trades at prices ranging from $15.00 to $15.32, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. These transactions were executed in multiple trades at prices ranging from $15.00 to $15.07, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. /s/ Jacqueline E. Shea 2021-02-03